Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis : JCR: Journal of Clinical Rheumatology

Secondary Logo

Journal Logo

Original Articles

Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis

A Systematic Review and Network Meta-analysis

Alves, Carlos PhD∗,†; Penedones, Ana PhD∗,†; Mendes, Diogo PhD∗,†; Marques, Francisco Batel PhD∗,†

Author Information
JCR: Journal of Clinical Rheumatology 28(2):p 69-76, March 2022. | DOI: 10.1097/RHU.0000000000001804

Abstract

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid